[July 07, 2015] |
|
Dr. Anita Goel, M.D., Ph.D., Nanobiosym Chairman and CEO, Wins Galactic Grant to Fund Gene-RADAR® Research in Space
Nanobiosym®, a global nanotechnology firm, today announced that its
Chairman and CEO, Dr. Anita Goel, M.D., Ph.D, has been awarded the top
prize in the Galactic Grant Competition to fund the Nanobiosym Research
Institute to push the frontier of nanobiophysics and the Gene-RADAR®
technology on the International Space Station (ISS), U.S. National
Laboratory.
Uniquely trained as both a physicist and medical doctor at Stanford,
Harvard, and MIT (News - Alert), Dr. Goel has, over the past 20 years, pioneered and
established through her Nanobiosym Research Institute, a new science at
the convergence of Physics, Biomedicine, Nanotechnology and Information
Communications Technology. From this science Dr. Goel has developed a
commercial product called Gene-RADAR®, a mobile tricorder-like device
that enables gold standard real-time diagnosis of any disease with a
genetic fingerprint. Gene-RADAR® recently won the prestigious XPRIZE -
an international competition that recognizes breakthrough technologies
that benefit humanity on an exponential scale.
"I am delighted to accept this award and launch this pivotal partnership
between Nanobiosym and the ISS to develop new 'apps' for our Gene-RADAR®
technology," said Dr. Goel. "The microgravity environment on the ISS
makes biological organisms mutate faster. Gene- RADAR® on the ISS will
help us better predict how deadly pathogens here on Earth can mutate to
become drug-resistant superbugs, such as MRSA. Our ability to anticipate
drug-resistant mutations with Gene-RADAR® will lead to next generation
antibiotics that are more precisely tailored to stop the spread of the
world's most dangerous pathogens. We will leverage our research on the
ISS to accelerate the Precision Medicine revolution here on Earth."
Massachusetts Governor Charlie Bker joined leaders from NASA, the
Center for the Advancement of Science in Space (CASIS) and the
Massachusetts Life Sciences Center (MLSC) to present the Galactic Grant
award to Dr. Goel, Tuesday, July 7, 2015 as part of the ISS Research &
Development Conference taking place in Boston this week.
"Collaboration is one of our greatest strengths in Massachusetts, and
through this first-ever collaboration between CASIS and the MLSC local
companies have had the unique opportunity to compete for funds to
support innovative life sciences experiments on the International Space
Station," said Governor Charlie Baker (News - Alert). "Congratulations to the winners
of this competition, and I look forward to seeing the results of this
important research."
Dr. Goel is also a featured speaker at this conference alongside other
innovators who are pushing the frontier of Space Research to improve
life on Earth such as SpaceX (News - Alert) and Tesla CEO Elon Musk, other premier
scientists, and three active NASA astronauts.
According to global
experts, drug-resistant infections, if they are not tackled could kill
an extra 10 million people every year by 2050 and cost the global
economy at least $100 trillion in lost output.
For more information, visit www.nanbiosym.com
and www.iss-casis.org.
About Nanobiosym, NBSDx, Gene-RADAR®, and Dr. Anita Goel, MD, PhD
Nanobiosym Diagnostics (NBSDx) is commercializing Gene-RADAR® to bring
real-time mobilized diagnosis of global health infectious diseases to
the nearly four billion people today who have no access to centralized
diagnostics labs. Dr. Goel's commercial vision at NBSDx is to
democratize the healthcare industry the same way Google (News - Alert) transformed the
information industry and cell phones decentralized the telecom industry.
By providing next-gen tools that decentralize, personalize, and mobilize
the delivery of healthcare, we empower each person to take ownership
over their own health.
About Nanobiosym Research Institute (NBS (News - Alert))
Nanobiosym (NBS) is an innovation engine dedicated to creating a new
science that emerges from the holistic integration of physics,
biomedicine, ICT, and nanotechnology. NBS focuses on incubating
transformational technologies that have the potential for exponential
impact to address the biggest global challenges of our time, in global
health, energy and the environment.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150707006378/en/
[ Back To Mobile World Congress's Homepage ]
|